Haleon (XTER:H6D0) Inventories, Finished Goods : €0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Inventories, Finished Goods?

Haleon's quarterly finished goods increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€1,265 Mil) but then declined from Dec. 2023 (€1,265 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual finished goods increased from Dec. 2021 (€790 Mil) to Dec. 2022 (€1,153 Mil) and increased from Dec. 2022 (€1,153 Mil) to Dec. 2023 (€1,265 Mil).

Haleon Inventories, Finished Goods Historical Data

The historical data trend for Haleon's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Inventories, Finished Goods Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

971.95

715.94

789.67

1,153.27

1,265.23

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial									-	-	-	1,265.23	-

Haleon Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Haleon (XTER:H6D0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK HLN:UK

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines